Concepedia

Jennifer L. Crombie

JL

32

Publications

1.4K

Citations

19

H-Index

2012

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Massachusetts General Hospital

Beth Israel Deaconess Medical Center

Harvard University

The University of Texas MD Anderson Cancer Center

Jennifer L. Crombie is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and immunology.

ORCID

Top concepts

Publications per year

2012–2024

32

Publications

32

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Matthew J. Frigault, Jörg Dietrich, María Martínez-Lage et al. · Blood · 2019 · 229 citations · Full text

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Philippe Armand, Yi‐Bin Chen, Robert Redd et al. · Blood · 2019 · 178 citations · Full text

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

Jennifer L. Crombie, Tara Graff, Lorenzo Falchi et al. · Blood · 2024 · 106 citations · Full text

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

Matthew S. Davids, Benjamin L. Lampson, Svitlana Tyekucheva et al. · The Lancet Oncology · 2021 · 100 citations

, , +10

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

Matthew S. Davids, Danielle M. Brander, Haesook T. Kim et al. · The Lancet Haematology · 2019 · 70 citations · Full text

, , +11

Rows per page

1–5 of 32